Search
Elaine Mosqueda has traveled far in so many ways since moving from the Philippines to the United States at the age of 21.
We are thrilled to welcome 20 undergraduates to our ten-week course mentored by GSK’s outstanding faculty.
The MSK Clinical Research Roundup keeps physicians up to date on the latest and most noteworthy patient treatments, clinical trials, and translational research happening at MSK.
Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at risk for disease recurrence and precisely tailor treatment to overcome drug resistance.
Meet the winners of the 2022 Robbins Family Awards for Excellence at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body's inflammatory and immunological responses to them play in the development of cancer.
Learn more about the risks and benefits of the shingles vaccine for cancer patients and their caregivers.
Learn how a support group could help you if you’ve been diagnosed with metastatic breast cancer.
Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.
There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells. Historically, CAR T cell immunotherapy has aimed to boost the immune system by giving immune cells the information they need to better recognize tumor cells as foreign and attack them. New work led by Hans-Guido Wendel, MD, of Memorial Sloan Kettering Cancer Center (MSK), and collaborator Karin Tarte of the University of Rennes, France, illustrates an untapped potential of CAR T cells to act as targeted delivery vehicles that can function as “micro-pharmacies” for precise therapeutic delivery.